1 November 2016
		 |  Stephen James Broomfield 
 
		 
 
			   
		
		
			 
			These two animal studies report on potential new applications for intra-tympanic OTO-104, a slow-release hydrogel formulation of dexamethasone that is currently being used in a Europe-wide randomised trial for Ménière’s disease. In the first paper, guinea pigs were given a...